Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 19 | 2024 | 17346 | 1.100 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2020 | 14 | 0.740 |
Why?
|
Relapsing Fever | 1 | 2020 | 24 | 0.730 |
Why?
|
Borrelia | 1 | 2020 | 66 | 0.710 |
Why?
|
AIDS Dementia Complex | 2 | 2019 | 153 | 0.690 |
Why?
|
RNA, Viral | 4 | 2021 | 2846 | 0.670 |
Why?
|
Cerebral Infarction | 2 | 2020 | 983 | 0.630 |
Why?
|
Muscle Weakness | 2 | 2022 | 413 | 0.610 |
Why?
|
Crack Cocaine | 1 | 2017 | 32 | 0.580 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 664 | 0.550 |
Why?
|
Activins | 2 | 2009 | 210 | 0.550 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2016 | 9 | 0.540 |
Why?
|
Drug Resistance, Viral | 2 | 2018 | 861 | 0.500 |
Why?
|
Ovarian Diseases | 1 | 2016 | 137 | 0.490 |
Why?
|
Dementia | 4 | 2024 | 2686 | 0.480 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1665 | 0.470 |
Why?
|
Encephalitis | 3 | 2022 | 438 | 0.460 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 219 | 0.460 |
Why?
|
Cocaine-Related Disorders | 1 | 2017 | 461 | 0.450 |
Why?
|
Immune Evasion | 1 | 2017 | 363 | 0.440 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 256 | 0.430 |
Why?
|
Vasospasm, Intracranial | 1 | 2015 | 215 | 0.420 |
Why?
|
HIV-1 | 6 | 2023 | 6860 | 0.390 |
Why?
|
Apolipoprotein E4 | 1 | 2016 | 708 | 0.390 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1875 | 0.380 |
Why?
|
HIV | 1 | 2018 | 1582 | 0.380 |
Why?
|
Autopsy | 4 | 2023 | 1006 | 0.370 |
Why?
|
Meningitis | 2 | 2022 | 218 | 0.360 |
Why?
|
Depression | 2 | 2021 | 8122 | 0.330 |
Why?
|
Brain | 11 | 2023 | 27103 | 0.320 |
Why?
|
Cognition Disorders | 1 | 2023 | 3979 | 0.320 |
Why?
|
Skin Diseases | 1 | 2017 | 1092 | 0.310 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2017 | 2199 | 0.310 |
Why?
|
Metagenomics | 3 | 2021 | 467 | 0.300 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 441 | 0.290 |
Why?
|
Confusion | 2 | 2020 | 278 | 0.280 |
Why?
|
Cerebrospinal Fluid | 2 | 2020 | 544 | 0.280 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 687 | 0.270 |
Why?
|
Central Nervous System | 6 | 2022 | 1337 | 0.260 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 485 | 0.260 |
Why?
|
Hypoxia, Brain | 1 | 2006 | 138 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3080 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3200 | 0.260 |
Why?
|
Inflammation | 3 | 2021 | 10760 | 0.250 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3223 | 0.250 |
Why?
|
Lipids | 1 | 2016 | 3341 | 0.250 |
Why?
|
Alleles | 1 | 2016 | 6909 | 0.250 |
Why?
|
Depressive Disorder | 1 | 2017 | 3728 | 0.230 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2023 | 32 | 0.220 |
Why?
|
Enzyme Activation | 1 | 2009 | 3592 | 0.220 |
Why?
|
Humans | 56 | 2024 | 761326 | 0.220 |
Why?
|
Anti-HIV Agents | 2 | 2018 | 4524 | 0.210 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2023 | 142 | 0.210 |
Why?
|
CD4 Lymphocyte Count | 3 | 2018 | 2569 | 0.210 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1023 | 0.210 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 7 | 0.210 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 1 | 2022 | 53 | 0.200 |
Why?
|
Viral Load | 4 | 2023 | 3330 | 0.200 |
Why?
|
Cognition | 5 | 2023 | 6987 | 0.200 |
Why?
|
Middle Aged | 27 | 2024 | 220774 | 0.190 |
Why?
|
Brain Neoplasms | 1 | 2023 | 9030 | 0.190 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 40 | 0.190 |
Why?
|
Encephalitis, California | 1 | 2020 | 5 | 0.190 |
Why?
|
Herpesviridae Infections | 1 | 2022 | 270 | 0.190 |
Why?
|
Encephalitis Virus, California | 1 | 2020 | 9 | 0.190 |
Why?
|
Ischemic Attack, Transient | 1 | 2006 | 879 | 0.190 |
Why?
|
Metagenome | 2 | 2021 | 450 | 0.180 |
Why?
|
Dehydroepiandrosterone | 1 | 2021 | 258 | 0.170 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12972 | 0.170 |
Why?
|
Paresis | 1 | 2021 | 176 | 0.170 |
Why?
|
Brain Injuries | 2 | 2022 | 2053 | 0.170 |
Why?
|
Herpes Zoster | 1 | 2022 | 253 | 0.170 |
Why?
|
Speech Disorders | 1 | 2020 | 180 | 0.170 |
Why?
|
Exanthema | 1 | 2023 | 504 | 0.160 |
Why?
|
Frontotemporal Dementia | 1 | 2021 | 247 | 0.160 |
Why?
|
Policy | 1 | 2022 | 508 | 0.150 |
Why?
|
Male | 30 | 2024 | 360621 | 0.150 |
Why?
|
Neurocysticercosis | 1 | 2019 | 91 | 0.150 |
Why?
|
Pituitary-Adrenal System | 1 | 2021 | 551 | 0.150 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2018 | 41 | 0.150 |
Why?
|
Viruses | 1 | 2021 | 376 | 0.150 |
Why?
|
Peripheral Nerves | 1 | 2021 | 479 | 0.140 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2018 | 47 | 0.140 |
Why?
|
Chemokines | 1 | 2021 | 960 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 753 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 700 | 0.140 |
Why?
|
Fatigue | 2 | 2022 | 1551 | 0.140 |
Why?
|
Neurofilament Proteins | 1 | 2019 | 336 | 0.140 |
Why?
|
Female | 26 | 2024 | 392485 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 575 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 36430 | 0.130 |
Why?
|
Pancytopenia | 1 | 2017 | 102 | 0.130 |
Why?
|
Frail Elderly | 1 | 2021 | 763 | 0.130 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 133 | 0.130 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1530 | 0.130 |
Why?
|
Adult | 17 | 2023 | 221122 | 0.130 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2021 | 1896 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1025 | 0.120 |
Why?
|
Anti-Retroviral Agents | 2 | 2022 | 1782 | 0.120 |
Why?
|
Retrospective Studies | 10 | 2023 | 80575 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15835 | 0.120 |
Why?
|
Sarcoma, Kaposi | 1 | 2017 | 374 | 0.110 |
Why?
|
Aged | 16 | 2024 | 169179 | 0.110 |
Why?
|
Heart Rate | 2 | 2022 | 4197 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1317 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4567 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2021 | 1815 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1886 | 0.110 |
Why?
|
Antibodies, Viral | 2 | 2021 | 3155 | 0.110 |
Why?
|
Genotype | 2 | 2018 | 12982 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1403 | 0.100 |
Why?
|
Brain Diseases | 1 | 2022 | 1545 | 0.100 |
Why?
|
Methotrexate | 1 | 2019 | 1720 | 0.100 |
Why?
|
Prospective Studies | 7 | 2021 | 54405 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2021 | 1491 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1198 | 0.100 |
Why?
|
Proteomics | 2 | 2022 | 3843 | 0.100 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 560 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2727 | 0.100 |
Why?
|
Herpesvirus 3, Human | 2 | 2022 | 159 | 0.100 |
Why?
|
Homozygote | 1 | 2016 | 1796 | 0.090 |
Why?
|
Brain Abscess | 1 | 2012 | 120 | 0.090 |
Why?
|
Neurons | 2 | 2009 | 9458 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2017 | 1420 | 0.090 |
Why?
|
Blood Pressure | 2 | 2022 | 8485 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2625 | 0.080 |
Why?
|
Injections, Intraventricular | 1 | 2009 | 225 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1791 | 0.080 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 343 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4550 | 0.080 |
Why?
|
Risk Factors | 4 | 2023 | 74152 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3638 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6224 | 0.080 |
Why?
|
United States | 7 | 2024 | 72317 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2021 | 7045 | 0.080 |
Why?
|
Blood Gas Analysis | 1 | 2009 | 379 | 0.080 |
Why?
|
Neurology | 1 | 2016 | 778 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2956 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3335 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2570 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7390 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4173 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4927 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2683 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20555 | 0.060 |
Why?
|
Phenotype | 1 | 2023 | 16603 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14597 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 22124 | 0.060 |
Why?
|
Stroke | 2 | 2023 | 9749 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8635 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 728 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3572 | 0.050 |
Why?
|
Proteome | 2 | 2022 | 1863 | 0.050 |
Why?
|
Dysgeusia | 1 | 2022 | 15 | 0.050 |
Why?
|
Orthostatic Intolerance | 1 | 2022 | 23 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8592 | 0.050 |
Why?
|
Proviruses | 1 | 2023 | 313 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9994 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6937 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4850 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2022 | 191 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6231 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6839 | 0.050 |
Why?
|
Basal Ganglia | 1 | 2023 | 554 | 0.050 |
Why?
|
Young Adult | 2 | 2018 | 59196 | 0.050 |
Why?
|
Microglia | 1 | 2009 | 1357 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4419 | 0.040 |
Why?
|
Limit of Detection | 1 | 2021 | 272 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15262 | 0.040 |
Why?
|
Hypertension | 1 | 2020 | 8539 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13500 | 0.040 |
Why?
|
Unconsciousness | 1 | 2022 | 250 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18401 | 0.040 |
Why?
|
Aging | 3 | 2024 | 8704 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2022 | 269 | 0.040 |
Why?
|
Animals | 3 | 2023 | 168388 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2023 | 822 | 0.040 |
Why?
|
Up-Regulation | 1 | 2006 | 4120 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2022 | 701 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 553 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3744 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10764 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1722 | 0.040 |
Why?
|
Life Expectancy | 1 | 2024 | 1242 | 0.030 |
Why?
|
Cell Survival | 1 | 2006 | 5792 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2022 | 710 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14665 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2022 | 1303 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2023 | 4812 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3420 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41440 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39108 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1399 | 0.030 |
Why?
|
Memory Disorders | 1 | 2022 | 1198 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 665 | 0.030 |
Why?
|
Headache | 1 | 2022 | 1256 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1162 | 0.030 |
Why?
|
Marijuana Abuse | 1 | 2017 | 411 | 0.030 |
Why?
|
Rats | 1 | 2009 | 23729 | 0.030 |
Why?
|
Liver Diseases | 1 | 2021 | 1296 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1329 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1596 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6086 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 65 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2006 | 12787 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15499 | 0.020 |
Why?
|
Mice | 2 | 2009 | 81474 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 18962 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10075 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10715 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5776 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18234 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2022 | 1852 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8632 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3577 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6236 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2697 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 1037 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2722 | 0.020 |
Why?
|
Time Factors | 1 | 2009 | 39974 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58946 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10498 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3202 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6478 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21336 | 0.020 |
Why?
|
Sleep | 1 | 2021 | 4765 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20092 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6758 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15719 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5841 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6309 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14025 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29588 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30044 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26108 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64645 | 0.010 |
Why?
|